Relay Therapeutics (RLAY) Target Price Raised to $25 by H.C. Wainwright
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowH.C. Wainwright has increased the stock price target for Relay Therapeutics (RLAY) to $25. This adjustment reflects the research firm's updated outlook on the company's growth potential and performance metrics. The new price target suggests a positive sentiment towards Relay Therapeutics' market position. Analysts' revisions can significantly influence investor perception and trading behavior.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News
Wall Street Futures Steady After Dow Jumps 146 Points Ahead of Fed Meeting
Oct 26
Stewart Information Services Director Bradley Allen Jr. Buys $94,600 Stock
Oct 26
TSX Stocks Recommended After Carney’s Investing Summit
Oct 26
SoFi Technologies (SOFI) Growth Strong but Rate Sensitivity Dampens Outlook
Oct 26